Keyword: advanced metastatic melanoma
With a new green light in Europe in lung cancer, Novartis just took another step in expanding the market for its targeted Tafinlar-plus-Mekinist combination therapy.
Cheered by “extraordinarily high” efficacy in chemo-free combo studies, Roche is powering into late-stage trials with two different melanoma-fighting cocktails based on its brand-new immunotherapy Tecentriq.
Japan's Oncolys BioPharma wants to muscle in on Amgen's cancer-killing virus for melanoma. The biotech has filed to start trials of its version in U.S. melanoma patients, just a few months after the Amgen product was cleared by the FDA.
SkinJect, a Pittsburgh-based device company, said it reached a deal with the University of Pittsburgh to license a minimally invasive treatment for common forms of nonmelanoma skin cancer, basal cell and squamous cell carcinoma.
Despite years of noted failures and struggles in the field, groups are pushing on in cancer vaccines with a variety of approaches. In new work published in Nature, a team now claims it may have the beginnings of what could become a “universal” cancer vaccine.